ATIR101 administered after Tcelldepleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia

ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia

09:55 EST 11 Feb 2020 | Nature Publishing

More From BioPortfolio on "ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia"